TCG Crossover Management, LLC

Position in ADCT — ADC Therapeutics SA

CIK 1839948 PALO ALTO, CA

Back to ADCT Full portfolio

Position in ADCT

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$42,713,156

+$2,505,839 QoQ

Shares Held

11,390,175

0.0% QoQ

Ownership

8.96%

of shares outstanding

% of Portfolio

1.22%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2025

3 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in ADCT Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

TCG Crossover Management, LLC holds $249,632,788 across 4 Drug Manufacturers - Specialty & Generic names. ADCT ranks #3 (17.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	BCRX	Biocryst Pharmaceuticals Inc	11,020,968	$104,919,615
2	AMLX	Amylyx Pharmaceuticals, Inc.	6,243,812	$86,788,986
3	ADCT	ADC Therapeutics SA This page	11,390,175	$42,713,156
4	LQDA	Liquidia Corp	403,048	$15,211,031

All Filings in ADCT

Export CSV

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$42,713,156	11,390,175	0.0%	Shares	Sole	2026-05-15
2025-12-31	$40,207,317	11,390,175	+719.3%	Shares	Sole	2026-02-17
2025-09-30	$5,560,700	1,390,175	—	Shares	Sole	2025-11-17
No filing history on record for this holder in this stock.